Skip to Content

GS XJG (Tykerb 250 mg)

Generic Name: lapatinib

Pill with imprint GS XJG is Orange, Elliptical / Oval and has been identified as Tykerb 250 mg. It is supplied by GlaxoSmithKline.

Tykerb is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Tykerb 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GS XJG

Tykerb

Generic Name:
lapatinib
Imprint:
GS XJG
Strength:
250 mg
Color:
Orange
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
EGFR inhibitors
HER2 inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
FD&C Yellow No. 6
hypromelloses
polyethylene glycol
polysorbate 80
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00078-0671 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide